227 filings
Page 6 of 12
8-K
4c1lx593qr npiric
30 Oct 18
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
8:12am
8-K
itwy nqpel
26 Oct 18
Entry into a Material Definitive Agreement
5:23pm
8-K
tj0zia88 b1d550b3x
23 Oct 18
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
5:24pm
8-K
xh3c3onl2j1mc 0vm8m
10 Aug 18
NeoGenomics Announces Pricing on Public Offering of Common Stock
10:29am
8-K
p5g3vd4drcxyq
6 Aug 18
NeoGenomics Announces Proposed Public Offering of Common Stock
4:42pm
8-K
rzf18lqe pd0z
24 Jul 18
NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
8:11am
8-K
xo4vczrdl 22hs
25 Jun 18
Entry into a Material Definitive Agreement
4:58pm
8-K
iy2 9yugyxmt6676
12 Jun 18
Regulation FD Disclosure
12:00am
8-K
6iz19
6 Jun 18
Submission of Matters to a Vote of Security Holders
5:10pm
8-K
geetll kz30i
1 Jun 18
Other Events
4:48pm
8-K
ftra06c8hcu0 q62me
25 May 18
Regulation FD Disclosure
5:11pm
8-K
91rjv1kqfe0it3 hf6
25 May 18
Regulation FD Disclosure
5:06pm
8-K
alpbaglf
7 May 18
Departure of Directors or Certain Officers
5:20pm
8-K
9zosfbc f4vv
1 May 18
NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018
7:52am
8-K
nqmjfazyd8fcx
19 Apr 18
2017 Annual Report One Company One Culture One Mission
12:00am
8-K
lh4793vnm zuhsohw
23 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
j3vky5 8fdy4rm
20 Mar 18
NeoGenomics Announces Executive Appointments
12:00am
8-K
p81yzi 5spjdpkl
21 Feb 18
NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
12:00am
8-K
3gwz21nrp1
25 Oct 17
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
12:00am
8-K
9md2w
17 Oct 17
Departure of Directors or Certain Officers
12:00am